A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

NCT04983810 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult
Lymphoma

Interventions

DRUG: Fadraciclib

Sponsor

Cyclacel Pharmaceuticals, Inc.